Gemcitabine & Nab-Paclitaxel in Pancreatic Adenocarcinoma With Positive Peritoneal Cytology

NCT03703089 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Adenocarcinoma

Interventions

DRUG: Gemcitabine
DRUG: nab-paclitaxel

Sponsor

Benaroya Research Institute